Tong Ren Tang Technologies Co. Ltd. (SEHK: 1666)
Health Care · Pharmaceuticals · CN
HK$3.05
-0.33% today · -37.5% 1Y
Tong Ren Tang Technologies Co. Ltd. (SEHK: 1666) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $496.97M and employs 3,801 people.
Over the last twelve months the share price has lost 37.5%, trading between 2.96 and 4.95.
Tweenvest scores Tong Ren Tang Technologies Co. Ltd. across four factors: quality 79/100, value 83/100, growth 36/100, dividend 45/100. Its strongest factor is value.
1666 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $496.97M
- Revenue (TTM)
- $849.40M
- P/E
- 11.01
- EPS
- 0.24
- Dividend yield
- 6.93%
- Beta (5Y)
- 0.75
- 52-week high
- HK$4.95
- 52-week low
- HK$2.96
- Avg volume (3M)
- —
- Shares outstanding
- 1.28B
- Employees
- 3,801
- Next earnings
- —
About Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co. Ltd., a company founded in 1669 and based in Beijing, People's Republic of China, maintains extensive operations across Mainland China and Hong Kong. Its primary activities center on the manufacturing and sale of traditional Chinese medicine products. The company's involvement is comprehensive, extending to the cultivation, sourcing, and distribution of Chinese medicinal raw materials. Beyond its core offerings, Tong Ren Tang diversifies its product portfolio with items such as ointments, tea beverages, and specialized foot care solutions. The enterprise is also active in the technological advancement and commercialization of biological products, alongside Western pharmaceuticals, cosmetics, and general healthcare goods. Its distribution network includes both wholesale and retail channels for Chinese medicines and health-related products. Furthermore, Tong Ren Tang provides a broad spectrum of services, including medical research and development, Chinese medical consultation and treatment, advertising, internal and external surgical procedures, medical examinations, and hospital management. Additionally, the company engages in the processing of biochemical products, plant extraction, and the production of various food and daily chemical items.
- ISIN
- CNE100000585
- Founded
- 1669
- Listed since
- Oct 31, 2000
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Contineum Therapeutics, Inc.NasdaqGS: CTNM | $503.37M | $13.38 | +1.52% |
| Tibet AIM Pharm. Inc.SZSE: 002826 | $501.71M | CN¥17.68 | +0.51% |
| Arvinas, Inc.NasdaqGS: ARVN | $499.55M | $7.64 | +1.73% |
| Guangdong Lifestrong Pharmacy Co., Ltd.SZSE: 301111 | $499.25M | CN¥20.90 | -1.88% |
| YungShin Global Holding CorporationTWSE: 3705 | $492.33M | NT$59.10 | +4.97% |
| Daewoong Co., Ltd.KOSE: A003090 | $490.60M | ₩15,690.00 | +2.28% |
| Zhejiang Haisen Pharmaceutical Co., Ltd.SZSE: 001367 | $488.63M | CN¥21.77 | -1.09% |
| Gujarat Themis Biosyn LimitedBSE: 506879 | $488.50M | Rs363.25 | -5.00% |
Figures last refreshed Oct 11, 2026.